Fluorescent Platinum Nanodrugs

  • ChemPubSoc Europe Logo
  • Author: Theresa Kueckmann
  • Published Date: 10 December 2015
  • Source / Publisher: Chemistry – An Asian Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Fluorescent Platinum Nanodrugs

Platinum drugs have been widely used as clinical anti-tumor agents, but they have severe side effects and short circulating time in blood. Nanodrugs can preferentially accumulate within solid tumors, thus reducing off-target toxicity and improving the therapeutic index.


Zhigang Xie, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, and colleagues prepared two fluorescent nanodrugs based on small-molecule cyanine-platinum conjugates (E)-4-(2-(1H-indol-3-yl)vinyl)-pyridine-platinum (HIP-Pt) and (E)-4-(2-(1-methyl-1H-indol-3-yl)vinyl)-pyridine-platinum (MIP-Pt). The conjugates, which comprise a hydrophobic cyanine dye moiety and a hydrophilic cisplatin-like moiety, self-assemble in water to form nanoparticles approximately 70 nm in diameter.


These nanodrugs combine the advantages of high drug content and nanoscale sizes. Moreover, HIP-Pt and MIP-Pt exhibited enhanced fluorescence in their nanoparticle formulation. The nanoparticles could be endocytosed by cancer cells and showed high cellular proliferation inhibition. These results demonstrate the promise of the self-assembly of small-molecule drugs with both imaging and therapeutic functions for the development of novel nanomedicines.


 

Article Views: 2632

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH